For research use only. Not for therapeutic Use.
Ticagrelor（Cat No.:A000779）is a potent antiplatelet medication widely used in cardiovascular therapy. It prevents blood clots by inhibiting the P2Y12 receptor on platelets, reducing the risk of heart attacks and strokes in patients with acute coronary syndrome or a history of myocardial infarction. Unlike other antiplatelets, Ticagrelor offers reversible binding, providing a flexible option in clinical settings. Its rapid onset and potent effects make it a preferred choice in emergency and maintenance therapy. Ticagrelor enhances patient outcomes through improved vascular protection and reduced cardiovascular events.
| Catalog Number | A000779 |
| CAS Number | 274693-27-5 |
| Synonyms | 274693-27-5; Brilinta; Brilique; AZD-6140; AZD6140 |
| Molecular Formula | C23H28F2N6O4S |
| Purity | ≥95% |
| Target | P2Y Receptor |
| Solubility | >26.2mg/mL in DMSO |
| Storage | -20°C |
| IUPAC Name | (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| InChI | InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1 |
| InChIKey | OEKWJQXRCDYSHL-FNOIDJSQSA-N |
| SMILES | CCCSC1=NC(=C2C(=N1)N(N=N2)C3CC(C(C3O)O)OCCO)NC4CC4C5=CC(=C(C=C5)F)F |
